EQUITY (DEFICIT) (Tables)

9 Months Ended

Sep. 30, 2014

Schedule Of Common Stock, Capital Shares Reserved For Future Issuance [Table Text Block]

The Company is authorized to issue up to 147,397,390 shares of common stock. At September 30, 2014, shares of common stock reserved for future issuance are as follows:

Stock options outstanding		1,381,500
Warrants outstanding		1,425,000
Stock options available for grant		2,159,250
Restricted shares		300,000
		5,265,750

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]

The stock-based compensation expense recorded by the Company for the nine months ended September 30, 2014 and 2013, with respect to awards under the Company’s stock plans are as follows:

	2014		2013
Research and development	$	995	$	4,582
General and administrative	$	–	$	–
Total employee stock-based compensation	$	995	$	4,582

Schedule Of Share Based Compensation Stock Options Activity [Table Text Block]

The following is a summary of the Company’s stock option activity:

Weighted

Average

Remaining

Aggregate

Exercise

Contractual

Intrinsic

Price

Term

Value

Outstanding at January 1, 2014

1,381,500

0.91

Granted

–

Exercised

–

Forfeited

–

Outstanding at September 30, 2014

1,381,500

0.91

4.09 years

28,000

Options Exercisable at September 30, 2014

1,341,500

0.91

4.09 years

28,000

Schedule Of Share Based Compensation Warrant Activities [Table Text Block]

The following is a summary of the Company’s warrant activity:

					Weighted
			Weighted		Average
			Average		Remaining	Aggregate
			Exercise		Contractual	Intrinsic
	Shares		Price		Term	Value
Outstanding at January 1, 2014		1,625,000	$	0.45
Granted		–	$	–		$	-
Forfeited		(200,000)	$	2.50
Outstanding at September 30, 2014		1,425,000	$	0.16	0.32 years	$	157,500
Exercisable at September 30, 2014		1,425,000	$	0.16	0.32 years	$	157,500

ONCOVISTA INNOVATIVE THERAPIES, INC 10-Q